<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id>
<journal-title>Frontiers in Immunology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Immunol.</abbrev-journal-title>
<issn pub-type="epub">1664-3224</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fimmu.2023.1256425</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Immunology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>
<italic>Leishmania braziliensis</italic> exosomes activate human macrophages to produce proinflammatory mediators</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Peixoto</surname>
<given-names>Fabio C.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2362356"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zanette</surname>
<given-names>Dalila L.</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cardoso</surname>
<given-names>Thiago M.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/492027"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nascimento</surname>
<given-names>Mauricio T.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1020724"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sanches</surname>
<given-names>Rodrigo C. O.</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/882465"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Aoki</surname>
<given-names>Mateus</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1824926"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Scott</surname>
<given-names>Phillip</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/24753"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Oliveira</surname>
<given-names>S&#xe9;rgio C.</given-names>
</name>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
<xref ref-type="aff" rid="aff7">
<sup>7</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/58620"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Carvalho</surname>
<given-names>Edgar M.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff7">
<sup>7</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/599290"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Carvalho</surname>
<given-names>Lucas P.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff7">
<sup>7</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/67482"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Laborat&#xf3;rio de Pesquisas Cl&#xed;nicas (LAPEC), Instituto Gon&#xe7;alo Moniz (IGM), Oswaldo Cruz Foundation (FIOCRUZ)</institution>, <addr-line>Salvador, Bahia</addr-line>, <country>Brazil</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Programa de P&#xf3;s Gradua&#xe7;&#xe3;o em Ci&#xea;ncias da Sa&#xfa;de, Universidade Federal da Bahia, UFBA</institution>, <addr-line>Salvador, Bahia</addr-line>, <country>Brazil</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Laboratory for Applied Science and Technology in Health, Instituto Carlos Chagas &#x2013; Oswaldo Cruz Foundation (FIOCRUZ) Paran&#xe1; (ICC)</institution>, <addr-line>Curitiba, Paran&#xe1;</addr-line>, <country>Brazil</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Departamento de Bioqu&#xed;mica e Imunologia, Universidade Federal de Minas Gerais</institution>, <addr-line>Belo Horizonte, Minas Gerais</addr-line>, <country>Brazil</country>
</aff>
<aff id="aff5">
<sup>5</sup>
<institution>University of Pennsylvania, School of Veterinary Medicine</institution>, <addr-line>Philadelphia, PA</addr-line>, <country>United States</country>
</aff>
<aff id="aff6">
<sup>6</sup>
<institution>Departamento de Imunologia, Instituto de Ciencias Biom&#xe9;dicas, Universidade de S&#xe3;o Paulo</institution>, <addr-line>S&#xe3;o Paulo</addr-line>, <country>Brazil</country>
</aff>
<aff id="aff7">
<sup>7</sup>
<institution>Instituto Nacional de Ci&#xea;ncias e Tecnologia-Doen&#xe7;as Tropicais</institution>, <addr-line>Salvador</addr-line>, <country>Brazil</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Ulisses Gazos Lopes, Federal University of Rio de Janeiro, Brazil</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Peter Epeh Kima, University of Florida, United States; Namrata Anand, University of Kentucky, United States</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Lucas P. Carvalho, <email xlink:href="mailto:carvalholp76@gmail.com">carvalholp76@gmail.com</email>; Fabio C. Peixoto, <email xlink:href="mailto:fabio99peixoto@gmail.com">fabio99peixoto@gmail.com</email>
</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>27</day>
<month>09</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>14</volume>
<elocation-id>1256425</elocation-id>
<history>
<date date-type="received">
<day>10</day>
<month>07</month>
<year>2023</year>
</date>
<date date-type="accepted">
<day>30</day>
<month>08</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2023 Peixoto, Zanette, Cardoso, Nascimento, Sanches, Aoki, Scott, Oliveira, Carvalho and Carvalho</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Peixoto, Zanette, Cardoso, Nascimento, Sanches, Aoki, Scott, Oliveira, Carvalho and Carvalho</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Exosomes, organelles measuring 30-200nm, are secreted by various cell types. <italic>Leishmania</italic> exosomes consist of many proteins, including heat shock proteins, annexins, Glycoprotein 63, proteins exerting signaling activity and those containing mRNA and miRNA. Studies have demonstrated that <italic>Leishmania donovani</italic> exosomes downregulate IFN-&#x3b3; and inhibit the expression of microbicidal molecules, such as TNF and nitric oxide, thus creating a microenvironment favoring parasite proliferation. Despite lacking immunological memory, data in the literature suggest that, following initial stimulation, mononuclear phagocytes may become &#x201c;trained&#x201d; to respond more effectively to subsequent stimuli. Here we characterized the effects of macrophage sensitization using <italic>L. braziliensis</italic> exosomes prior to infection by the same pathogen. Human macrophages were stimulated with <italic>L. braziliensis</italic> exosomes and then infected with <italic>L. braziliensis</italic>. Higher levels of IL-1&#x3b2; and IL-6 were detected in cultures sensitized prior to infection compared to unstimulated infected cells. Moreover, stimulation with <italic>L. braziliensis</italic> exosomes induced macrophage production of IL-1&#x3b2;, IL-6, IL-10 and TNF. Inhibition of exosome secretion by <italic>L. braziliensis</italic> prior to macrophage infection reduced cytokine production and produced lower infection rates than untreated infected cells. Exosome stimulation also induced the consumption/regulation of NLRP3 inflammasome components in macrophages, while the blockade of NLRP3 resulted in lower levels of IL-6 and IL-1&#x3b2;. Our results suggest that <italic>L. braziliensis</italic> exosomes stimulate macrophages, leading to an exacerbated inflammatory state that may be NLRP3-dependent.</p>
</abstract>
<kwd-group>
<kwd>Leishmania braziliensis</kwd>
<kwd>exosome</kwd>
<kwd>macrophage</kwd>
<kwd>immune response</kwd>
<kwd>innate immunity</kwd>
</kwd-group>
<counts>
<fig-count count="8"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="57"/>
<page-count count="11"/>
<word-count count="4924"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>Microbial Immunology</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<p>Cutaneous leishmaniasis (CL), due to <italic>L. braziliensis</italic> infection, is characterized by the presence of few or rare parasites, a predominance of lymphocytes and mononuclear phagocytes in the inflammatory infiltrate (<xref ref-type="bibr" rid="B1">1</xref>). Host immunological factors are known to play an important role in the pathogenesis of this disease. Mononuclear cells from CL patients stimulated with soluble <italic>Leishmania</italic> antigen (SLA) produce exacerbated amounts of IFN- &#x3b3; and TNF, as well as low levels of IL-10 in culture (<xref ref-type="bibr" rid="B2">2</xref>). While the production of IFN-&#x3b3; is important for parasite killing, high levels of TNF have been associated with tissue damage and lesion development (<xref ref-type="bibr" rid="B2">2</xref>, <xref ref-type="bibr" rid="B3">3</xref>). Studies on lesion tissue samples have confirmed the contribution of inflammation to ulcer development, as evidenced by the presence of Granzyme B produced by CD8+ and NK cells, in addition to metalloproteinases and inflammatory cytokines (<xref ref-type="bibr" rid="B4">4</xref>&#x2013;<xref ref-type="bibr" rid="B11">11</xref>). Moreover, <italic>Leishmania braziliensis</italic>-infected mononuclear phagocytes have been shown to produce high levels of reactive oxygen species (ROS), molecules with leishmanicidal properties that have also been associated with tissue damage (<xref ref-type="bibr" rid="B12">12</xref>, <xref ref-type="bibr" rid="B13">13</xref>).</p>
<p>An important role of IL-1&#x3b2; in CL pathogenesis has been documented in recent years, with the use of IL-1&#x3b2; inhibitors shown to improve the course of disease in murine models (<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B12">12</xref>). In humans, IL-1&#x3b2; concentrations were found to correlate with lesion size, and previous research by our group has documented elevated expression of the NLRP3 inflammasome in monocytes obtained from the peripheral blood of CL patients, in addition to high levels of IL-1&#x3b2; in cultured peripheral blood mononuclear cells (PBMC) stimulated with SLA (<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B14">14</xref>). Moreover, NLRP3<sup>-/-</sup> BALB/c mice infected with <italic>L. major</italic> demonstrated a greater ability to control <italic>Leishmania</italic> infection when compared to wild-type mice (<xref ref-type="bibr" rid="B15">15</xref>).</p>
<p>
<italic>Leishmania</italic>, and its soluble products, can trigger immune responses in innate immune cells prior to the onset of mononuclear cellular infection (<xref ref-type="bibr" rid="B13">13</xref>, <xref ref-type="bibr" rid="B16">16</xref>, <xref ref-type="bibr" rid="B17">17</xref>). For instance, <italic>Leishmania</italic> lipophosphoglycan (LPG) and DNA can induce the production of inflammatory mediators by mononuclear phagocytes through the activation of toll-like receptors (TLR) 2, 4 and 9 (<xref ref-type="bibr" rid="B18">18</xref>&#x2013;<xref ref-type="bibr" rid="B20">20</xref>). Pathogen molecules are often secreted via extracellular vesicles (EV), also known as exosomes.</p>
<p>Exosomes, organelles ranging in size from 30-200nm, are secreted by various cell types. The invagination of regions of the endosomal membrane results in the formation of multivesicular bodies (MVB); the fusion of MVBs with the plasm membrane leads to exosome secretion (<xref ref-type="bibr" rid="B21">21</xref>, <xref ref-type="bibr" rid="B22">22</xref>). These vesicles play a major role in molecular trafficking, e.g., proteins and nucleic acids, which once delivered may modulate host macrophage function (<xref ref-type="bibr" rid="B23">23</xref>&#x2013;<xref ref-type="bibr" rid="B29">29</xref>). For example, glycoprotein (gp) 63-containing <italic>Leishmania</italic> exosomes was shown to induce TNF production by macrophages and exacerbate pathology in a CL mouse model (<xref ref-type="bibr" rid="B28">28</xref>, <xref ref-type="bibr" rid="B30">30</xref>&#x2013;<xref ref-type="bibr" rid="B32">32</xref>).</p>
<p>The present study aimed to assess the effects of <italic>L. braziliensis</italic> exosomes on human macrophagic responses, revealing that these vesicles induce both IL-1&#x3b2; and IL-6 production. Moreover, the pre-exposure of macrophages to <italic>L. braziliensis</italic> exosomes was found to prime these cells to enhance the production of pro-inflammatory mediators in response to <italic>L. braziliensis</italic> infection, potentially contributing to the pathogenesis of disease.</p>
</sec>
<sec id="s2">
<title>Methods</title>
<sec id="s2_1">
<title>Parasite culture</title>
<p>An <italic>L. braziliensis</italic> isolate (MHOM/BR/LTCP11245) previously obtained from a CL patient&#x2019;s skin lesion was initially cultivated in biphasic medium (NNN). After isolation, parasites were identified by multilocus enzyme electrophoresis and cryopreserved in liquid nitrogen. Following selection, parasites were expanded and cultivated in Schneider&#x2019;s culture medium (SIGMA) supplemented with 20% inactive fetal bovine serum (FBS) (GIBCO), 1% L-glutamine and antibiotics.</p>
</sec>
<sec id="s2_2">
<title>L. braziliensis exosome isolation and characterization</title>
<p>
<italic>L. braziliensis</italic> promastigotes were cultured at 37&#xb0;C under 5% CO<sub>2</sub> for 4 hours to optimize protein and vesicle secretion (<xref ref-type="bibr" rid="B31">31</xref>). Supernatants collected from <italic>in vitro</italic> cultures were centrifuged (2500rpm) and filtered (0.22 &#xb5;m), after which exosomes were isolated through sequential ultracentrifugation (10 x 10<sup>5</sup>g). The EV particle-size distribution was determined by diffraction analysis using a NS300 particle-size tracker and Nanosight NTA 3.0 software using light scatter mode (Malvern Instruments Ltd., Technologies, Malvern, UK) (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1</bold>
</xref>) (<xref ref-type="bibr" rid="B33">33</xref>&#x2013;<xref ref-type="bibr" rid="B35">35</xref>).</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>
<bold>(A)</bold> Image of <italic>L. Braziliensis</italic> exosomes taken by a NS300 particle-sike tracker and Nanosight NTA 3.0 software using light scatter mode. <bold>(B)</bold> Quantification and Characterization of extracellular vesicles extracted from isolates of <italic>L. braziliensis</italic>.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-14-1256425-g001.tif"/>
</fig>
</sec>
<sec id="s2_3">
<title>Isolation and culturing of peripheral blood mononuclear cells</title>
<p>Peripheral blood mononuclear cells (PBMC) were obtained from heparinized venous blood from healthy subjects by Ficoll-paque density gradient centrifugation (GE Healthcare). Cells were washed twice in saline, and monocytes were isolated from PBMCs using magnetic beads in accordance with the manufacturer&#x2019;s protocol (Dynabeads untouched human monocytes; Invitrogen Dynal AS, Oslo, Norway). This process was performed twice, after which cells were washed in phosphate-buffered saline (PBS), then adjusted to the desired concentration, and resuspended in RPMI 1640 (GIBCO BRL., Grand Island, NY USA) supplemented with 10% FBS (GIBCO BRL., Grand Island, NY USA) and antibiotics. Monocytes were then allowed to adhere to polystyrene culture plates and incubated for 6 days at 37&#xb0;C under 5% CO<sub>2</sub> until differentiation into macrophages, as previously described (<xref ref-type="bibr" rid="B36">36</xref>).</p>
</sec>
<sec id="s2_4">
<title>Macrophage infection with L. braziliensis after stimulation with L. braziliensis soluble factors</title>
<p>Monocyte-derived macrophages (3 x 10<sup>5</sup>) were stimulated, using a transwell membrane, with soluble factors from <italic>L. braziliensis</italic> for 24 hours at 37 &#xb0;C, 5% CO<sub>2</sub> in RPMI (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2A</bold>
</xref>). Following stimulation, cells were washed twice in saline and infected or not with <italic>L. braziliensis</italic> (MOI 5:1) for 2 hours. Next, the remaining promastigotes were washed out, and cells were reincubated for another 24 hours at 37 &#xb0;C, 5% CO<sub>2</sub> in RPMI. The slides were subsequently submitted to panoptic staining for posterior quantification of infected macrophages and amastigotes per 100 cells via optical microscopy.</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>Macrophages from HS infected with <italic>L. braziliensis</italic> after sensitization with <italic>L. braziliensis</italic> through a transwell membrane (0,4&#xb5;m). <bold>(A)</bold> Stimulation strategy. <bold>(B)</bold> Cytokine production by macrophages sensitized with soluble factors and infected with <italic>L. braziliensis</italic>. <bold>(C)</bold> Cytokine production by macrophages from HS sensitized with soluble factors from <italic>L. braziliensis</italic>. Levels of IL-1&#x3b2;, TNF, IL-10 and IL-6 were determined in culture supernatants by LUMINEX. Statistical analyses were performed using the Wilcoxon rank test *p&lt;.05, **p&lt;.01.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-14-1256425-g002.tif"/>
</fig>
</sec>
<sec id="s2_5">
<title>Exosome stimulation and macrophage infection with L. braziliensis</title>
<p>Monocyte-derived macrophages (3x10<sup>5</sup>) were stimulated with exosomes from <italic>L. braziliensis</italic> (300 vesicles/macrophage) for 24 hours at 37&#xb0;C under 5% CO<sub>2</sub> in RPMI. After stimulation, cells were washed twice in saline and infected or not with <italic>L. braziliensis</italic> (MOI 5:1) for 2 hours. The remaining promastigotes were washed out, then cells were incubated for another 24 hours (37 &#xb0;C, 5% CO<sub>2</sub>) in RPMI.</p>
</sec>
<sec id="s2_6">
<title>Parasite treatment with GW4869</title>
<p>For some experiments involving the inhibition of exosome/vesicle generation, 1x10<sup>7</sup> <italic>Leishmania</italic>/mL were treated with GW4869 (20ng/ml), a vesicle generation inhibitor, (<ext-link ext-link-type="uri" xlink:href="https://www.sigmaaldrich.com/BR/pt/product/sigma/d1692">https://www.sigmaaldrich.com/BR/pt/product/sigma/d1692</ext-link>) for 30 minutes at room temperature, then washed three times to prevent contact between the inhibitor and human cells during stimulation/infection protocols. To assess GW4869 toxicity against <italic>Leishmania</italic> parasites, we evaluated <italic>L. braziliensis</italic> viability after treatment with GW4869 using propidium iodide as cell death marker, by flow cytometry.</p>
</sec>
<sec id="s2_7">
<title>Macrophage treatment with glibenclamide</title>
<p>For the blockade of the NLRP3 inflammasome, monocyte-derived macrophages (3x10<sup>5</sup>) were first treated with the NLRP3 inhibitor glibenclamide (100&#xb5;M) for 2 hours, then stimulated with L. braziliensis exosomes (300:1) for 24 hours. Cells were then washed twice and infected or not with L. braziliensis (MOI 5:1) for 2 hours, washed again to remove any remaining promastigotes, and finally incubated for 24 hours at 37 &#xb0;C under 5% CO<sub>2</sub>in RPMI. Unstimulated macrophages and untreated stimulated cells were used as controls.</p>
</sec>
<sec id="s2_8">
<title>Infection rate assessment</title>
<p>To evaluate infection rate, 3x10<sup>5</sup> macrophages/well were plated on Nunc<sup>&#xae;</sup> Labtek<sup>&#xae;</sup> plates and stimulated with exosomes from <italic>L. braziliensis</italic> (300 vesicles/macrophage), then incubated for 24 hours at 37&#xb0; C with 5% CO<sub>2</sub>. Cells were then washed twice and infected or not with <italic>L. braziliensis</italic> (MOI 5:1) for 2 hours, washed again to remove any remaining promastigotes, and finally incubated for 24 hours at 37 &#xb0;C under 5% CO<sub>2</sub> in RPMI. The slides were submitted to panoptic staining for the later quantification of infected macrophages and the number of amastigotes per 100 cells, performed via optical microscopy.</p>
</sec>
<sec id="s2_9">
<title>Cytokine quantification</title>
<p>Following stimulation and/or infection protocols, the supernatants from cultures were collected for cytokine (IL-1&#x3b2;, TNF, IL-6 and IL-10) quantification via Luminex (Bio-Plex Pro Human Cytokine 27-plex Assay) or ELISA.</p>
</sec>
<sec id="s2_10">
<title>Flow cytometry</title>
<p>Monocyte-derived macrophages from healthy subjects were stimulated with <italic>L. braziliensis</italic> exosomes for 24 hours and infected or not with <italic>L. braziliensis</italic> for another 24 hours, as described above. After the final incubation, cells were collected and placed in 5mL polystyrene FACS tubes (BD Biosciences Falcon&#x2122; 352052) for cell labeling with conjugated antibodies &#x3b1;CD14 (APC) and &#x3b1;HLA-DR (PerCP) to determine cell populations of interest, as well as &#x3b1;NLRP3 (PE). Events were acquired on a flow cytometer (BD LSRFortessa&#x2122; Cell analyzer) and data were analyzed using Flowjo<sup>&#xae;</sup> software.</p>
</sec>
<sec id="s2_11">
<title>Oxidative burst essay</title>
<p>To evaluate reactive oxygen species (ROS) production, macrophages were stimulated as described in &#x201c;Exosome Stimulation and Macrophage infection with <italic>L. braziliensis</italic>&#x201d; section, then treated with dihydrorhodamine-123 at 10ng/mL (Cayman Chemical Company) for 10 minutes. Cells were subsequently labeled with &#x3b1;HLA-DR and &#x3b1;CD14 to evaluate fluorescence intensity by flow cytometry, with data analysis performed via FlowJo<sup>&#xae;</sup> software.</p>
</sec>
<sec id="s2_12">
<title>RNA extraction, NF-&#x3ba;B and TLR2 gene expression</title>
<p>Cells stimulated with exosomes and infected or not with <italic>L. braziliensis</italic>, followed by incubation at 37&#xb0;C under 5% CO<sub>2</sub> for 2 hours, were harvested in TRIzol Reagent (Invitrogen). RNA extraction was performed using TRIzol RNA isolation, according to manufacturer&#x2019;s instructions. RNA concentration and integrity were determined by spectrophotometric optical density measurements (260 and 280 nm). Gene expression was analyzed performed as previously described (<xref ref-type="bibr" rid="B37">37</xref>).</p>
</sec>
<sec id="s2_13">
<title>Mouse macrophage cultures and infection</title>
<p>C57BL/6 mice, both wild-type and others genetically deficient for NLRP3<sup>&#x2212;/&#x2212;</sup>, were obtained as previously described (<xref ref-type="bibr" rid="B38">38</xref>). All animals were maintained at the UFMG Animal Facility and used for experimentation at 6&#x2013;8 weeks of age. Bone marrow-derived macrophages (BMDM) were prepared and infected as previously described (<xref ref-type="bibr" rid="B39">39</xref>, <xref ref-type="bibr" rid="B40">40</xref>). Briefly, bone marrow cells were isolated from the femurs and tibias of the animals, cultured in RPMI 1640 supplemented with 30% L929 cell-conditioned medium and 20% FBS for 7 days. BMDM (0.5&#xd7;10<sup>6</sup>) were treated or not with lipopolysaccharide (LPS) for 6 hours (500 ng/ml) and stimulated or not with <italic>L. braziliensis</italic> exosomes (300:1), followed by infection with stationary phase <italic>Leishmania braziliensis</italic> (MOI 10:1) for 24 hours. After 48 hours, supernatants were harvested and IL-1&#x3b2;, TNF and IL-6 concentrations were detected by ELISA.</p>
</sec>
<sec id="s2_14">
<title>Statistical analysis</title>
<p>Statistical analysis was performed using the Wilcoxon test for paired variables and Mann-Whitney rank test for unpaired measurements (*p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, ****p&lt;0.0001). All experimental data were analyzed using Prism GraphPad<sup>&#xae;</sup> 8.0.2, which was also used for graphical data representations.</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<title>Results</title>
<sec id="s3_1">
<title>L. braziliensis soluble factors induce pro-inflammatory mediator production in human macrophages</title>
<p>Macrophages can be &#x201c;trained&#x201d; to enhance response to infection (<xref ref-type="bibr" rid="B41">41</xref>). For instance, macrophages exposed to <italic>Saccharomyces cerevisiae</italic> demonstrated an increased ability to produce TNF in response to TLR ligands, such as LPS (<xref ref-type="bibr" rid="B42">42</xref>). To investigate whether soluble factors from <italic>L. braziliensis</italic> would interfere in cytokine production, human macrophages were cultured with <italic>L. braziliensis</italic> separated by a membrane, which allowed only soluble factors/small molecules to cross the barrier. Macrophages exposed to <italic>L. braziliensis</italic> products through the membrane produced more IL-1&#x3b2; upon infection than those that were not previously exposed to parasite factors (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2B</bold>
</xref>). Moreover, exposure to <italic>L. braziliensis</italic> soluble factors was also shown to induce the production of inflammatory mediators TNF, IL-6 and IL-1&#x3b2; by uninfected macrophages (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2C</bold>
</xref>). This data provides evidence that exposure to <italic>L. braziliensis</italic> modulates immune response prior to the establishment of cellular infection.</p>
</sec>
<sec id="s3_2">
<title>L. braziliensis exosomes induce pro-inflammatory mediator production by human macrophages</title>
<p>We first investigated whether <italic>L. braziliensis</italic> exosomes induced an inflammatory response in macrophages, and then assessed the effects of stimulating macrophages with these vesicles prior to infection with <italic>L. braziliensis.</italic> Compared to unstimulated cells, macrophages stimulation with EVs were found to induce IL-1&#x3b2;, TNF, IL-10 and IL-6 production (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3</bold>
</xref>). Pre-sensitization of macrophages with exosomes prior to infection was shown to increase IL-1&#x3b2; and IL-6 levels (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3</bold>
</xref>). Similarly, pre-sensitization with exosomes produced no influence on infection rate, nor the number of parasites internalized (data not shown).</p>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>Cytokine production by macrophages from HS sensitized with <italic>L. braziliensis</italic> exosomes and infected with <italic>L. braziliensis</italic>. Macrophages from HS (n=8) were stimulated with exosomes isolated from <italic>L. braziliensis</italic> (300:1) for 24 hours and afterwards infected or not with <italic>L. braziliensis</italic> for another 24 hours. Levels of IL-1&#x3b2;, TNF, IL-10 and IL-6 were determined in culture supernatants by LUMNEX. Statistical analyses were performed using the Wilcoxon rank test *p&lt;.05, **p&lt;.01.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-14-1256425-g003.tif"/>
</fig>
</sec>
<sec id="s3_3">
<title>Blockade of L. braziliensis exosome generation inhibits Leishmania-induced cytokine production by human macrophages</title>
<p>To further ascertain the role of exosomes in inducing inflammatory cytokine production, we infected human macrophages with <italic>L. braziliensis</italic> previously treated with GW4869, and then compared cytokine expression with other untreated <italic>Leishmania-</italic>infected cells. As in the experiments above, our data shows that cells infected with exosome-free <italic>L. braziliensis</italic> produced significantly less IL-1&#x3b2;, TNF, IL-10 and IL-6 upon infection (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4A</bold>
</xref>). Although no differences were observed in parasite internalization by macrophages pre-sensitized with exosomes compared to unstimulated cells (data not shown), the cells infected with exosome-free <italic>L. braziliensis</italic> presented less infectivity, as evidenced by fewer numbers of infected macrophages and lower numbers of amastigotes within the cells (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4B</bold>
</xref>). As treatment with GW4869 could have interfered with <italic>L. braziliensis</italic> survival, we performed a dose-response curve with different GW4869 concentrations. Our experiments show no toxicity of GW4869 over <italic>L. braziliensis</italic> (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4C</bold>
</xref>).</p>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>
<bold>(A)</bold> Cytokine production and <bold>(B)</bold> Infection rate of macrophages from HS infected with <italic>L. braziliensis</italic> with exosome production inhibited. Axenic culture of <italic>L. braziliensis</italic> promastigotes was treated with GW4869 (20ng/ml), exosome production inhibitor, for 2 hours. Macrophages from HS (n=8) were infected with GW4869 treated <italic>L. braziliensis</italic> (5:1) for 24 hours. <bold>(C)</bold> <italic>L. braziliensis</italic> viability after GW4869 treatment was assessed using propidium iodide as cell death marker, by flow cytometry. <bold>(D)</bold> optical microscopy picture of panoptic stained macrophages infected with <italic>L. braziliensis</italic> treated (left) or not (right) with GW4869. Levels of IL-1&#x3b2;, TNF, IL-10 and IL-6 were determined in culture supernatants by LUMNEX. The percentage of infected cells as well as the number of intracellular parasites were determined by microscopic evaluation after panoptic staining. Statistical analyses were performed using the Wilcoxon rank test *p&lt;.05, **p&lt;.01.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-14-1256425-g004.tif"/>
</fig>
</sec>
<sec id="s3_4">
<title>L. braziliensis exosomes induce NLRP3 consumption/regulation</title>
<p>Most of the data presented in this study demonstrate the important association between <italic>L. braziliensis</italic> exosomes and IL-1&#x3b2; production. Consequently, the participation of NLRP3 in IL-1&#x3b2; production was investigated by evaluating both the expression of NLRP3 protein by cultured macrophages (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5A</bold>
</xref>) and the production of cytokines by cells stimulated with exosomes after the blockade of NLRP3 through glibenclamide treatment (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5B</bold>
</xref>). Our results indicate lower NLRP3 protein expression in cells stimulated with exosomes for 24 hours compared to basal level cells, while exosome stimulation in macrophages prior to infection induced more consumption, and probably further expression regulation, of this inflammasome than unsensitized cells (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5A</bold>
</xref>), which corroborates our previous results. Moreover, glibenclamide-treated cells were found to secrete less IL-1&#x3b2;, TNF, IL-6 and IL-10 than untreated cells, regardless of <italic>L. braziliensis</italic> infection or exosome stimulation. (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5B</bold>
</xref>), which suggests that cytokine expression induced by exosome stimulation is dependent on NLRP3.</p>
<fig id="f5" position="float">
<label>Figure&#xa0;5</label>
<caption>
<p>
<bold>(A)</bold> Exosome stimulation enhance NLRP3 consumption by macrophages. Macrophages from healthy subjects (n=8) were sensitized with exosomes (300:1) for 24 hours and infected with <italic>L. braziliensis</italic> promastigotes for another 24 hours at a ratio of 5:1. Cells were stained with anti-CD14 and anti-NLRP3. Data were collected using flow cytometry and analyzed with FLOWJO<sup>&#xae;</sup> software. Representative gating strategy on CD14<sup>+</sup> expression in macrophages from one healthy subject. NLRP3 MFI was taken from CD14<sup>+</sup> population. The data represent the mean of fluorescence intensity (MFI) of NLRP3 expression by macrophages in the different stimulated groups. <bold>(B)</bold> Glyburide downmodulates exosome-induced cytokine production in macrophages from healthy subjects. Macrophages from 8 individuals were treated with glyburide (100&#xb5;M) for 2 hours. Afterwards cells were stimulated for 24 hours with <italic>L. braziliensis</italic> exosomes and infected with the parasite for another 24 hours. Levels of IL-1&#x3b2;, TNF, IL-10, IL-10 and IL-6 were measured in culture supernatant by ELISA. Statistical analyses were performed using the Mann-Whitney test for unpaired groups and Wilcoxon rank test for paired measurements *p&lt;.05 **p&lt;.01.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-14-1256425-g005.tif"/>
</fig>
</sec>
<sec id="s3_5">
<title>BMDM from NLRP3<sup>-/-</sup> C57BL/6 mice exhibit inhibited IL-1&#xdf; production following. braziliensis infection</title>
<p>The secretion of IL-1&#x3b2; may be dependent on inflammasome activation (<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B14">14</xref>, <xref ref-type="bibr" rid="B39">39</xref>). NLRP3, the main inflammasome receptor responsible for inducing IL-1&#x3b2; production, forms a complex with ASC and Caspase-1 for the processing and secretion of IL-1&#x3b2; and IL-18 (<xref ref-type="bibr" rid="B43">43</xref>, <xref ref-type="bibr" rid="B44">44</xref>). Since our results showed that <italic>L. braziliensis</italic> exosome stimulation followed by infection induced high levels of IL-1&#x3b2; secretion by human macrophages, we decided to investigate whether NLRP3 activation is required to drive IL-1&#x3b2; production upon <italic>L. braziliensis</italic> infection in a murine model.</p>
<p>Bone marrow-derived macrophages (BMDM) from C57BL/6 WT mice and mice deficient for NLRP3 were infected with <italic>L. braziliensis</italic> after previous stimulation with <italic>L. braziliensis</italic> exosomes. Levels of IL-1&#x3b2;, IL-6 and TNF were quantified by ELISA in cell supernatants. IL-1&#x3b2; production in mice was found to be dependent on the NLRP3 inflammasome, as IL-1&#x3b2; production was completely abrogated in cells from NLRP3<sup>-/-</sup> mice, regardless of stimulation. However, NLRP3 did not appear to be involved in the production of the other cytokines evaluated, as levels did not differ between WT and NLRP3<sup>-/-</sup> mouse cells (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6</bold>
</xref>).</p>
<fig id="f6" position="float">
<label>Figure&#xa0;6</label>
<caption>
<p>NLRP is key for <italic>L. braziliensis</italic> induced IL-1&#x3b2; production in mouse macrophages. BMDMs from wild-type C57BL/6 mices and deficient for NLRP3 were prepared, pulsed with LPS (500 ng/ml), stimulated with exosomes (300:1) and infected with <italic>L. braziliensis</italic> (MOI 10:1) or not. After 48 hours of culture ELISA for IL-1&#x3b2; was performed on supernatants. Statistical analyses were performed using the Mann-Whitney test and the Wilcoxon rank test. *p&lt;0.05, **p&lt;0.01.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-14-1256425-g006.tif"/>
</fig>
</sec>
<sec id="s3_6">
<title>L. braziliensis exosomes induce ROS production by macrophages</title>
<p>Our group previously showed that reactive oxygen species (ROS) constitute a major endogenous factor in <italic>Leishmania</italic> killing (<xref ref-type="bibr" rid="B13">13</xref>, <xref ref-type="bibr" rid="B45">45</xref>). Furthermore, TNF production is directly associated with ROS production through the activation of the NF-&#x3ba;B signaling pathway. Therefore, to investigate the role of <italic>L. braziliensis</italic> exosomes on ROS production, ROS expression (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7</bold>
</xref>) was evaluated in macrophages stimulated with exosomes further infected with <italic>L. braziliensis</italic>. Our data show that while <italic>L. braziliensis</italic> exosomes induced ROS production by uninfected macrophages, pre-sensitization did not interfere in ROS production following <italic>in vitro</italic> macrophage infection (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7</bold>
</xref>).</p>
<fig id="f7" position="float">
<label>Figure&#xa0;7</label>
<caption>
<p>Macrophagic stimulation with <italic>L. braziliensis</italic> exosomes enhance reactive oxygen species production. Macrophages from healthy subjects were evaluated after being stimulated with exosomes for 24 hours and infected with <italic>L. braziliensis</italic> for 24 hours (n=6) or not. The cells were treated with DHR (10ng/mL &#x2013; 10&#xa0;min) and stained with anti-CD14 and anti-HLA-DR. Data were collected using flow cytometry and analyzed by FLOWJO<sup>&#xae;</sup> software. <bold>(A)</bold> Representative gating strategy on CD14<sup>+</sup> and HLA-DR<sup>+</sup> expression in macrophages. DHR MFI were taken from CD14<sup>+</sup> HLA-DR<sup>+</sup> population. <bold>(B)</bold> The data represent the mean of fluorescence intensity (MFI) of oxidative burst production by macrophages stimulated with exosomes and infected with <italic>L. braziliensis</italic>. Statistical analyses were performed using the Wilcoxon rank test for paired measurements *p&lt;.05.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-14-1256425-g007.tif"/>
</fig>
</sec>
<sec id="s3_7">
<title>Macrophages stimulated with L. braziliensis exosomes express high levels of NF-&#x3ba;B and toll-like receptor 2</title>
<p>Herein <italic>L. braziliensis</italic> exosomes were found to induce TNF and ROS production by human macrophages. It has been shown that NF-kB activation induces TNF production through the activation of TLRs 2-4 upon <italic>L. braziliensis</italic> infection (<xref ref-type="bibr" rid="B18">18</xref>). To determine the role of <italic>L. braziliensis</italic> exosomes in TLR2 and NFkB expression, human macrophages were stimulated with EVs for 2 hours and infected or not with <italic>L. braziliensis</italic> for another 2 hours. Uninfected macrophages stimulated with exosomes were found to induce higher expression of NF-&#x3ba;B and TLR2 (<xref ref-type="fig" rid="f8">
<bold>Figure&#xa0;8</bold>
</xref>), yet infected cells previously stimulated with EVs demonstrated increased TLR2 expression, yet no effect on NF-&#x3ba;B expression (<xref ref-type="fig" rid="f8">
<bold>Figure&#xa0;8</bold>
</xref>). No differences were observed among the groups with regard to TLR4 expression. These data corroborate with our findings on exosome-induced TNF and ROS production, as these molecules are formed as a result of the NF-&#x3ba;B pathway.</p>
<fig id="f8" position="float">
<label>Figure&#xa0;8</label>
<caption>
<p>Macrophages stimulated with <italic>L. braziliensis</italic> exosomes express high levels of NF-&#x3ba;B and Toll-Like Receptor 2. <bold>(A)</bold> TLR2 and <bold>(B)</bold> NF-&#x3ba; B gene expression, represented as 2<sup>&#x2212;&#x394;&#x394;CT</sup>, following RT-PCR of RNA from macrophages-derived monocytes of HS (N=7) stimulated with exosomes for 24 hours and infected with <italic>L. braziliensis</italic> for 24 hours or not. Statistical analyses were performed using the Mann-Whitney test and the Wilcoxon rank test. *p&lt;0.05, **p&lt;0.01. ***p&lt;0.001.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-14-1256425-g008.tif"/>
</fig>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<title>Discussion</title>
<p>The initial events occurring upon <italic>Leishmania</italic> infection orchestrate immune response, constituting determinants in parasite proliferation and disease development. Among the factors contributing to disease expression, vector molecules, including salivary gland proteins, parasite-derived molecules and host immune response are of great importance (<xref ref-type="bibr" rid="B46">46</xref>, <xref ref-type="bibr" rid="B47">47</xref>). On the parasite side, attention has been paid to the role of exosomes due to the close relationship between molecules present in the exosomes and their ability to modulate host immune response (<xref ref-type="bibr" rid="B28">28</xref>, <xref ref-type="bibr" rid="B31">31</xref>, <xref ref-type="bibr" rid="B32">32</xref>). The present study documented that <italic>L. braziliensis</italic> exosomes indeed modulate immune response by priming macrophages to produce more inflammatory molecules.</p>
<p>It has recently been suggested that macrophages could become &#x201c;trained&#x201d; to enhance infection response (<xref ref-type="bibr" rid="B41">41</xref>). For instance, macrophages exposed to <italic>Saccharomyces cerevisiae</italic> demonstrated an increased ability to produce TNF in response to TLR ligands, such as LPS. Moreover, monocytes &#x201c;trained&#x201d; with <italic>S. cerevisiae</italic> demonstrated heightened microbial activity (<xref ref-type="bibr" rid="B42">42</xref>). In the same vein, our results additionally indicate that <italic>L. braziliensis</italic> exosomes effectively &#x201c;train&#x201d; macrophages to produce higher cytokine concentrations in response to posterior <italic>L. braziliensis</italic> infection, suggesting that epigenetics in macrophages may play a role in subsequent exposure to <italic>L. braziliensis</italic> components.</p>
<p>Clearly, <italic>Leishmania</italic> vesicle contents vary across species, and thereby exert variable effects on host immune response. For instance, studies have shown that exosomes from <italic>L. donovani</italic> modulate monocyte response to IFN-&#x3b3; and inhibit TNF while inducing IL-10 production. In this manner, mice stimulated with <italic>L. donovani</italic> exosomes prior to infection with the same species were found to exhibit higher macrophage infection rates within the spleen (<xref ref-type="bibr" rid="B26">26</xref>, <xref ref-type="bibr" rid="B27">27</xref>). Also, stimulation with <italic>L. major</italic> exosomes prior to <italic>L. major</italic> parasite challenge produced a shift towards a Th2-type response in mice, as evidenced by a high frequency of CD4+ T cells producing IL-4, which led to disease exacerbation (<xref ref-type="bibr" rid="B27">27</xref>). Moreover, it was demonstrated that <italic>L. major</italic> exosomes contribute to CL pathology through the induction of an overproduction of inflammatory cytokines IL-23 and IL-17 in the lymph nodes of BALB/c mice (<xref ref-type="bibr" rid="B29">29</xref>).</p>
<p>The pathogenesis of <italic>Leishmania</italic> infection varies widely depending on the <italic>Leishmania</italic> species involved, and its specific effect on host immune response. In all cases, parasite control is associated with the expansion of CD4+ Th1 cells producing IFN-&#x3b3;, which promotes the killing of parasites within infected cells (<xref ref-type="bibr" rid="B48">48</xref>). In some cases, the parasite evades the immune system silently, without inducing an immunological response, as is the case in infection by <italic>L. donovani</italic>. In <italic>L. braziliensis</italic> infection, however, an exaggerated Th1 response is observed, together with high levels of proinflammatory cytokines and a predominance of lymphocytes and mononuclear phagocytes at the lesion site. Herein we demonstrate that stimulation with <italic>L. braziliensis</italic> exosomes induces high levels of proinflammatory cytokines (TNF and IL-1&#x3b2;) as well as ROS, molecules known to be involved in CL due to <italic>L. braziliensis</italic> pathogenesis. In our experiments where we treated <italic>L. braziliensis</italic> with GW4869, a vesicle secretion inhibitor, we observed a decrease in cytokines production in infected macrophages. However, since GW4869 also decreased <italic>L. braziliensis</italic> internalization, further studies need to be performed to understand the mechanism by which <italic>L. braziliensis</italic> exosomes interfere in <italic>Leishmania</italic> uptake.</p>
<p>Some <italic>Leishmania</italic> species are known to inhibit several macrophage functions, such as macrophage activation, cytokine release and antigen presentation. For instance, down-regulation of class II MHC expression and the inability to produce IL-12 has been observed in several studies (<xref ref-type="bibr" rid="B49">49</xref>&#x2013;<xref ref-type="bibr" rid="B54">54</xref>). Also, TLR-induced up-regulation of co-stimulatory molecules, as well as TNF-alpha and IL-12 production, was notably impaired in <italic>L. major, L. chagasi, L. donovani</italic> and <italic>L. mexicana</italic>-infected macrophages, while in the case of <italic>L. mexicana</italic>, disruption of NF-&#x3ba;B signaling was observed (<xref ref-type="bibr" rid="B55">55</xref>, <xref ref-type="bibr" rid="B56">56</xref>). In contrast, our results show that exosome sensitization increased the expression of NF-&#x3ba;B and TLR2, corroborating previously published data indicating that <italic>L. braziliensis</italic> infection promotes an inflammatory environment.</p>
<p>Inflammation is often associated with macrophage activation and intracellular parasite killing. Here we found that in spite of <italic>L. braziliensis</italic> exosomes enhancing IL-1b production by human macrophages, these vesicles have no effect on Leishmania parasite killing. These results are in accordance with our previous data showing no association between IL-1b production and L. brazileisns killing (<xref ref-type="bibr" rid="B8">8</xref>). Also, in our current results we found that exosomes do not increase the ability of macrophages to produce ROS in response to L. braziliensis infection, corroborating that these vesicles have no effect on L. braziliensis killing by macrophages. In the present study we found that the IL-1b production driven by <italic>L. braziliensis</italic> vesicles is NLPR3-dependent, corroborating our previous data involving <italic>L. braziliensis</italic>-infected macrophages (<xref ref-type="bibr" rid="B8">8</xref>). These findings favor the potential role of <italic>L. braziliensis</italic> EVs in the immunopathology observed in CL arising from <italic>L. braziliensis</italic>, in which ulcer development has been associated with an exaggerated inflammatory response that leads to tissue damage. Previous results have shown that IL-1&#x3b2; concentrations in CL due to <italic>L. braziliensis</italic> correlate positively with lesion size and healing time (<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B12">12</xref>). It has been documented that <italic>L. braziliensis</italic> infection activates the NLRP3 inflammasome, thereby inducing ROS (<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B39">39</xref>). Therefore, the blockade of NLRP3 may constitute a sound therapeutic approach.</p>
<p>Considering the physiology and dynamics of vesicle secretion, studies involving <italic>L. mexicana</italic> demonstrated a substantial increase in vesicle secretion at a temperature of 37&#x2da;C (<xref ref-type="bibr" rid="B31">31</xref>). Herein we observed a similar phenomenon in <italic>L. braziliensis</italic>. The up-regulation in vesicle release induced at infection-like temperatures suggests that parasites release vesicles into the extracellular environment prior to invading host cells. Similarly, it has been suggested that <italic>Leishmania</italic> exosomes interact with the host cell prior to the parasite itself, as evidenced by the presence of <italic>Leishmania</italic> molecules within uninfected macrophages (<xref ref-type="bibr" rid="B57">57</xref>). Moreover, as previous studies have shown that <italic>Leishmania</italic> secretes exosomes into the midgut of the sandfly vector, it has been hypothesized that these vesicles then become inoculated into the host alongside the parasite during sandfly blood-feeding, possibly enhancing the vesicle-induced effects of the parasite on immune response (<xref ref-type="bibr" rid="B29">29</xref>, <xref ref-type="bibr" rid="B32">32</xref>). Although both <italic>L. major</italic> and <italic>L. braziliensis</italic> cause CL, the magnitude of inflammation caused by both parasite species is quite different, as infection with <italic>L. braziliensis</italic> induces higher inflammatory response in humans than <italic>L. major</italic>. Thus, further experiments need to be performed to determine differences in the contents of exosomes between both species.</p>
<p>In contrast to previously published data indicating the downregulatory effects of <italic>L. donovoni</italic> and <italic>L. major</italic> exosomes, <italic>L. braziliensis</italic> exosomes do not appear to contribute to a microenvironment favorable for parasite growth, but instead participate in an exacerbated pathologic inflammatory response, which may potentially exacerbate lesion development.</p>
</sec>
<sec id="s5" sec-type="data-availability">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/supplementary materials. Further inquiries can be directed to the corresponding authors.</p>
</sec>
<sec id="s6" sec-type="ethics-statement">
<title>Ethics statement</title>
<p>The studies involving humans were approved by Institution Review Board of the Federal University of Bahia Medical School and the National Commission of Ethics in Research (CONEP) under the number 3.252.513. The studies were conducted in accordance with the local legislation and institutional requirements. The human samples used in this study were acquired from Peripheral blood was collected from healthy volunteers. Written informed consent for participation was not required from the participants or the participants&#x2019; legal guardians/next of kin in accordance with the national legislation and institutional requirements. The animal study was approved by Institutional Animal Care and Use Committee of the Federal University of Minas Gerais (CEUA no.&#xa0;165/2019). The study was conducted in accordance with the local legislation and institutional requirements.</p>
</sec>
<sec id="s7" sec-type="author-contributions">
<title>Author contributions</title>
<p>FP: Conceptualization, Data curation, Formal Analysis, Investigation, Methodology, Writing &#x2013; original draft, Writing &#x2013; review &amp; editing. DZ: Investigation, Methodology, Formal Analysis, Writing &#x2013; review &amp; editing. TC: Formal Analysis, Methodology, Writing &#x2013; review &amp; editing. MN: Investigation, Methodology, Writing &#x2013; review &amp; editing. RS: Methodology, Resources, Writing &#x2013; review &amp; editing. MA: Investigation, Writing &#x2013; review &amp; editing. PS: Funding acquisition, Resources, Visualization, Writing &#x2013; review &amp; editing. SO: Resources, Writing &#x2013; review &amp; editing. EC: Formal Analysis, Funding acquisition, Project administration, Resources, Supervision, Visualization, Writing &#x2013; review &amp; editing. LC: Conceptualization, Data curation, Formal Analysis, Funding acquisition, Investigation, Project administration, Resources, Supervision, Visualization, Writing &#x2013; original draft, Writing &#x2013; review &amp; editing.</p>
</sec>
</body>
<back>
<sec id="s8" sec-type="funding-information">
<title>Funding</title>
<p>This study was sponsored by the National Council for Scientific and Technological Development (CNPq), the National Institute of Health (NIH AI 136862) and AI149456a grant US-Brazil grant. The authors declare financial support was received for the research, authorship, and/or publication of this article.</p>
</sec>
<ack>
<title>Acknowledgments</title>
<p>We would like to thank Cristiano Sampaio Franco for secretarial assistance in the submission of this manuscript. The authors are also grateful to Andris K. Walter for English-language revision services and manuscript copyediting assistance and for the personal at Electronic Microscopy Platform- Fiocruz Bahia for assistance with acquiring the images. We thank Dr. Rachel DeRita from The Extracellular Vesicle Core Facility at The University of Pennsylvania.</p>
</ack>
<sec id="s9" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The authors declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.</p>
</sec>
<sec id="s10" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bittencourt</surname> <given-names>AL</given-names>
</name>
<name>
<surname>Barral</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Evaluation of the histopathological classifications of American cutaneous and mucocutaneous leishmaniasis</article-title>. <source>Mem Inst Oswaldo Cruz</source> (<year>1991</year>) <volume>86</volume>(<issue>1</issue>). doi: <pub-id pub-id-type="doi">10.1590/S0074-02761991000100009</pub-id>
</citation>
</ref>
<ref id="B2">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bacellar</surname> <given-names>O</given-names>
</name>
<name>
<surname>Lessa</surname> <given-names>H</given-names>
</name>
<name>
<surname>Schriefer</surname> <given-names>A</given-names>
</name>
<name>
<surname>MaChado</surname> <given-names>P</given-names>
</name>
<name>
<surname>De Jesus</surname> <given-names>AR</given-names>
</name>
<name>
<surname>Dutra</surname> <given-names>WO</given-names>
</name>
<etal/>
</person-group>. <article-title>Up-regulation of Th1-type responses in mucosal leishmaniasis patients</article-title>. <source>Infect Immun</source> (<year>2002</year>) <volume>70</volume>(<issue>12</issue>). doi: <pub-id pub-id-type="doi">10.1128/IAI.70.12.6734-6740.2002</pub-id>
</citation>
</ref>
<ref id="B3">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Passos</surname> <given-names>S</given-names>
</name>
<name>
<surname>Carvalho</surname> <given-names>LP</given-names>
</name>
<name>
<surname>Costa</surname> <given-names>RS</given-names>
</name>
<name>
<surname>Campos</surname> <given-names>TM</given-names>
</name>
<name>
<surname>Novais</surname> <given-names>FO</given-names>
</name>
<name>
<surname>Magalh&#xe3;es</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Intermediate monocytes contribute to pathologic immune response in leishmania Braziliensis infections</article-title>. <source>J Infect Dis</source> (<year>2015</year>) <volume>211</volume>(<issue>2</issue>). doi: <pub-id pub-id-type="doi">10.1093/infdis/jiu439</pub-id>
</citation>
</ref>
<ref id="B4">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Amorim</surname> <given-names>CF</given-names>
</name>
<name>
<surname>Novais</surname> <given-names>FO</given-names>
</name>
<name>
<surname>Nguyen</surname> <given-names>BT</given-names>
</name>
<name>
<surname>Misic</surname> <given-names>AM</given-names>
</name>
<name>
<surname>Carvalho</surname> <given-names>LP</given-names>
</name>
<name>
<surname>Carvalho</surname> <given-names>EM</given-names>
</name>
<etal/>
</person-group>. <article-title>Variable gene expression and parasite load predict treatment outcome in cutaneous leishmaniasis</article-title>. <source>Sci Transl Med</source> (<year>2019</year>) <volume>11</volume>(<issue>519</issue>). doi: <pub-id pub-id-type="doi">10.1126/scitranslmed.aax4204</pub-id>
</citation>
</ref>
<ref id="B5">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saldanha</surname> <given-names>MG</given-names>
</name>
<name>
<surname>Pagliari</surname> <given-names>C</given-names>
</name>
<name>
<surname>Queiroz</surname> <given-names>A</given-names>
</name>
<name>
<surname>MaChado</surname> <given-names>PRL</given-names>
</name>
<name>
<surname>Carvalho</surname> <given-names>L</given-names>
</name>
<name>
<surname>Scott</surname> <given-names>P</given-names>
</name>
<etal/>
</person-group>. <article-title>Tissue damage in human cutaneous leishmaniasis: correlations between inflammatory cells and molecule expression</article-title>. <source>Front Cell Infect Microbiol</source> (<year>2020</year>) <volume>10</volume>. doi: <pub-id pub-id-type="doi">10.3389/fcimb.2020.00355</pub-id>
</citation>
</ref>
<ref id="B6">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Campos</surname> <given-names>TM</given-names>
</name>
<name>
<surname>Passos</surname> <given-names>ST</given-names>
</name>
<name>
<surname>Novais</surname> <given-names>FO</given-names>
</name>
<name>
<surname>Beiting</surname> <given-names>DP</given-names>
</name>
<name>
<surname>Costa</surname> <given-names>RS</given-names>
</name>
<name>
<surname>Queiroz</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Matrix metalloproteinase 9 production by monocytes is enhanced by TNF and participates in the pathology of human cutaneous leishmaniasis</article-title>. <source>PloS Negl Trop Dis</source> (<year>2014</year>) <volume>8</volume>(<issue>11</issue>). doi: <pub-id pub-id-type="doi">10.1371/journal.pntd.0003282</pub-id>
</citation>
</ref>
<ref id="B7">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Campos</surname> <given-names>TM</given-names>
</name>
<name>
<surname>Novais</surname> <given-names>FO</given-names>
</name>
<name>
<surname>Saldanha</surname> <given-names>M</given-names>
</name>
<name>
<surname>Costa</surname> <given-names>R</given-names>
</name>
<name>
<surname>Lordelo</surname> <given-names>M</given-names>
</name>
<name>
<surname>Celestino</surname> <given-names>D</given-names>
</name>
<etal/>
</person-group>. <article-title>Granzyme B produced by natural killer cells enhances inflammatory response and contributes to the immunopathology of cutaneous leishmaniasis</article-title>. <source>J Infect Dis</source> (<year>2020</year>) <volume>221</volume>(<issue>6</issue>). doi: <pub-id pub-id-type="doi">10.1093/infdis/jiz538</pub-id>
</citation>
</ref>
<ref id="B8">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Santos</surname> <given-names>D</given-names>
</name>
<name>
<surname>Campos</surname> <given-names>TM</given-names>
</name>
<name>
<surname>Saldanha</surname> <given-names>M</given-names>
</name>
<name>
<surname>Oliveira</surname> <given-names>SC</given-names>
</name>
<name>
<surname>Nascimento</surname> <given-names>M</given-names>
</name>
<name>
<surname>Zamboni</surname> <given-names>DS</given-names>
</name>
<etal/>
</person-group>. <article-title>IL-1&#x3b2; Production by intermediate monocytes is associated with immunopathology in cutaneous leishmaniasis</article-title>. <source>J Invest Dermatol</source> (<year>2018</year>) <volume>138</volume>(<issue>5</issue>). doi: <pub-id pub-id-type="doi">10.1016/j.jid.2017.11.029</pub-id>
</citation>
</ref>
<ref id="B9">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Novais</surname> <given-names>FO</given-names>
</name>
<name>
<surname>Carvalho</surname> <given-names>LP</given-names>
</name>
<name>
<surname>Graff</surname> <given-names>JW</given-names>
</name>
<name>
<surname>Beiting</surname> <given-names>DP</given-names>
</name>
<name>
<surname>Ruthel</surname> <given-names>G</given-names>
</name>
<name>
<surname>Roos</surname> <given-names>DS</given-names>
</name>
<etal/>
</person-group>. <article-title>Cytotoxic T cells mediate pathology and metastasis in cutaneous leishmaniasis</article-title>. <source>PloS Pathog</source> (<year>2013</year>) <volume>9</volume>(<issue>7</issue>). doi: <pub-id pub-id-type="doi">10.1371/journal.ppat.1003504</pub-id>
</citation>
</ref>
<ref id="B10">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Novais</surname> <given-names>FO</given-names>
</name>
<name>
<surname>Scott</surname> <given-names>P</given-names>
</name>
</person-group>. <article-title>CD8+ T cells in cutaneous leishmaniasis: the good, the bad, and the ugly</article-title>. <source>Semin Immunopathology</source> (<year>2015</year>) <volume>37</volume>. doi: <pub-id pub-id-type="doi">10.1007/s00281-015-0475-7</pub-id>
</citation>
</ref>
<ref id="B11">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Santos</surname> <given-names>CDS</given-names>
</name>
<name>
<surname>Boaventura</surname> <given-names>V</given-names>
</name>
<name>
<surname>Ribeiro Cardoso</surname> <given-names>C</given-names>
</name>
<name>
<surname>Tavares</surname> <given-names>N</given-names>
</name>
<name>
<surname>Lordelo</surname> <given-names>MJ</given-names>
</name>
<name>
<surname>Noronha</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>CD8+ granzyme B+ -mediated tissue injury vs. CD4 + IFN&#x3b3;+ -mediated parasite killing in human cutaneous leishmaniasis</article-title>. <source>J Invest Dermatol</source> (<year>2013</year>) <volume>133</volume>(<issue>6</issue>). doi: <pub-id pub-id-type="doi">10.1038/jid.2013.4</pub-id>
</citation>
</ref>
<ref id="B12">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Novais</surname> <given-names>FO</given-names>
</name>
<name>
<surname>Carvalho</surname> <given-names>AM</given-names>
</name>
<name>
<surname>Clark</surname> <given-names>ML</given-names>
</name>
<name>
<surname>Carvalho</surname> <given-names>LP</given-names>
</name>
<name>
<surname>Beiting</surname> <given-names>DP</given-names>
</name>
<name>
<surname>Brodsky</surname> <given-names>IE</given-names>
</name>
<etal/>
</person-group>. <article-title>CD8+T cell cytotoxicity mediates pathology in the skin by inflammasome activation and IL-1&#x3b2; production</article-title>. <source>PloS Pathog</source> (<year>2017</year>) <volume>13</volume>(<issue>2</issue>). doi: <pub-id pub-id-type="doi">10.1371/journal.ppat.1006196</pub-id>
</citation>
</ref>
<ref id="B13">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carneiro</surname> <given-names>PP</given-names>
</name>
<name>
<surname>Concei&#xe7;&#xe3;o</surname> <given-names>J</given-names>
</name>
<name>
<surname>Macedo</surname> <given-names>M</given-names>
</name>
<name>
<surname>Magalh&#xe3;es</surname> <given-names>V</given-names>
</name>
<name>
<surname>Carvalho</surname> <given-names>EM</given-names>
</name>
<name>
<surname>Bacellar</surname> <given-names>O</given-names>
</name>
</person-group>. <article-title>The role of nitric oxide and reactive oxygen species in the killing of Leishmania Braziliensis by monocytes from patients with cutaneous leishmaniasis</article-title>. <source>PloS One</source> (<year>2016</year>) <volume>11</volume>(<issue>2</issue>). doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0148084</pub-id>
</citation>
</ref>
<ref id="B14">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carvalho</surname> <given-names>AM</given-names>
</name>
<name>
<surname>Novais</surname> <given-names>FO</given-names>
</name>
<name>
<surname>Paix&#xe3;o</surname> <given-names>CS</given-names>
</name>
<name>
<surname>de Oliveira</surname> <given-names>CI</given-names>
</name>
<name>
<surname>MaChado</surname> <given-names>PRL</given-names>
</name>
<name>
<surname>Carvalho</surname> <given-names>LP</given-names>
</name>
<etal/>
</person-group>. <article-title>Glyburide, a NLRP3 inhibitor, decreases inflammatory response and is a candidate to reduce pathology in leishmania Braziliensis infection</article-title>. <source>J Invest Dermatol</source> (<year>2020</year>) <volume>140</volume>(<issue>1</issue>). doi: <pub-id pub-id-type="doi">10.1016/j.jid.2019.05.025</pub-id>
</citation>
</ref>
<ref id="B15">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gurung</surname> <given-names>P</given-names>
</name>
<name>
<surname>Karki</surname> <given-names>R</given-names>
</name>
<name>
<surname>Vogel</surname> <given-names>P</given-names>
</name>
<name>
<surname>Watanabe</surname> <given-names>M</given-names>
</name>
<name>
<surname>Bix</surname> <given-names>M</given-names>
</name>
<name>
<surname>Lamkanfi</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>An NLRP3 inflammasome&#x2019;triggered Th2-biased adaptive immune response promotes leishmaniasis</article-title>. <source>J Clin Invest</source> (<year>2015</year>) <volume>125</volume>(<issue>3</issue>):<page-range>1329&#x2013;38</page-range>. doi: <pub-id pub-id-type="doi">10.1172/JCI79526</pub-id>
</citation>
</ref>
<ref id="B16">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carvalho</surname> <given-names>LP</given-names>
</name>
<name>
<surname>Pearce</surname> <given-names>EJ</given-names>
</name>
<name>
<surname>Scott</surname> <given-names>P</given-names>
</name>
</person-group>. <article-title>Functional dichotomy of dendritic cells following interaction with leishmania braziliensis: Infected cells produce high levels of TNF-&#x3b1;, whereas bystander dendritic cells are activated to promote T cell responses</article-title>. <source>J Immunol</source> (<year>2008</year>) <volume>181</volume>(<issue>9</issue>). doi: <pub-id pub-id-type="doi">10.4049/jimmunol.181.9.6473</pub-id>
</citation>
</ref>
<ref id="B17">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Becker</surname> <given-names>I</given-names>
</name>
<name>
<surname>Salaiza</surname> <given-names>N</given-names>
</name>
<name>
<surname>Aguirre</surname> <given-names>M</given-names>
</name>
<name>
<surname>Delgado</surname> <given-names>J</given-names>
</name>
<name>
<surname>Carrillo-Carrasco</surname> <given-names>N</given-names>
</name>
<name>
<surname>Kobeh</surname> <given-names>LG</given-names>
</name>
<etal/>
</person-group>. <article-title>Leishmania lipophosphoglycan (LPG) activates NK cells through toll-like receptor-2</article-title>. <source>Mol Biochem Parasitol</source> (<year>2003</year>) <volume>130</volume>(<issue>2</issue>). doi: <pub-id pub-id-type="doi">10.1016/S0166-6851(03)00160-9</pub-id>
</citation>
</ref>
<ref id="B18">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carneiro</surname> <given-names>PP</given-names>
</name>
<name>
<surname>D&#xf3;rea</surname> <given-names>AS</given-names>
</name>
<name>
<surname>Oliveira</surname> <given-names>WN</given-names>
</name>
<name>
<surname>Guimar&#xe3;es</surname> <given-names>LH</given-names>
</name>
<name>
<surname>Brodskyn</surname> <given-names>C</given-names>
</name>
<name>
<surname>Carvalho</surname> <given-names>EM</given-names>
</name>
<etal/>
</person-group>. <article-title>Blockade of TLR2 and TLR4 attenuates inflammatory response and parasite load in cutaneous leishmaniasis</article-title>. <source>Front Immunol</source> (<year>2021</year>) <volume>12</volume>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2021.706510</pub-id>
</citation>
</ref>
<ref id="B19">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carvalho</surname> <given-names>LP</given-names>
</name>
<name>
<surname>Petritus</surname> <given-names>PM</given-names>
</name>
<name>
<surname>Trochtenberg</surname> <given-names>AL</given-names>
</name>
<name>
<surname>Zaph</surname> <given-names>C</given-names>
</name>
<name>
<surname>Hill</surname> <given-names>DA</given-names>
</name>
<name>
<surname>Artis</surname> <given-names>D</given-names>
</name>
<etal/>
</person-group>. <article-title>Lymph Node Hypertrophy following Leishmania major Infection Is Dependent on TLR9</article-title>. <source>J Immunol</source> (<year>2012</year>) <volume>188</volume>(<issue>3</issue>). doi: <pub-id pub-id-type="doi">10.4049/jimmunol.1101018</pub-id>
</citation>
</ref>
<ref id="B20">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sacramento</surname> <given-names>LA</given-names>
</name>
<name>
<surname>da Costa</surname> <given-names>JL</given-names>
</name>
<name>
<surname>de Lima</surname> <given-names>MHF</given-names>
</name>
<name>
<surname>Sampaio</surname> <given-names>PA</given-names>
</name>
<name>
<surname>Almeida</surname> <given-names>RP</given-names>
</name>
<name>
<surname>Cunha</surname> <given-names>FQ</given-names>
</name>
<etal/>
</person-group>. <article-title>Toll-like receptor 2 is required for inflammatory process development during Leishmania infantum infection</article-title>. <source>Front Microbiol</source> (<year>2017</year>) <volume>8</volume>(<issue>FEB</issue>). doi: <pub-id pub-id-type="doi">10.3389/fmicb.2017.00262</pub-id>
</citation>
</ref>
<ref id="B21">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bobrie</surname> <given-names>A</given-names>
</name>
<name>
<surname>Colombo</surname> <given-names>M</given-names>
</name>
<name>
<surname>Raposo</surname> <given-names>G</given-names>
</name>
<name>
<surname>Th&#xe9;ry</surname> <given-names>C</given-names>
</name>
</person-group>. <article-title>Exosome secretion: molecular mechanisms and roles in immune responses</article-title>. <source>Traffic</source> (<year>2011</year>) <volume>12</volume>. doi: <pub-id pub-id-type="doi">10.1111/j.1600-0854.2011.01225.x</pub-id>
</citation>
</ref>
<ref id="B22">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Th&#xe9;ry</surname> <given-names>C</given-names>
</name>
<name>
<surname>Zitvogel</surname> <given-names>L</given-names>
</name>
<name>
<surname>Amigorena</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Exosomes: Composition, biogenesis and function</article-title>. <source>Nat Rev Immunol</source> (<year>2002</year>) <volume>2</volume>. doi: <pub-id pub-id-type="doi">10.1038/nri855</pub-id>
</citation>
</ref>
<ref id="B23">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Th&#xe9;ry</surname> <given-names>C</given-names>
</name>
<name>
<surname>Ostrowski</surname> <given-names>M</given-names>
</name>
<name>
<surname>Segura</surname> <given-names>E</given-names>
</name>
</person-group>. <article-title>Membrane vesicles as conveyors of immune responses</article-title>. <source>Nat Rev Immunol</source> (<year>2009</year>) <volume>9</volume>. doi: <pub-id pub-id-type="doi">10.1038/nri2567</pub-id>
</citation>
</ref>
<ref id="B24">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Raposo</surname> <given-names>G</given-names>
</name>
<name>
<surname>Stoorvogel</surname> <given-names>W</given-names>
</name>
</person-group>. <article-title>Extracellular vesicles: Exosomes, microvesicles, and friends</article-title>. <source>J Cell Biol</source> (<year>2013</year>) <volume>200</volume>. doi: <pub-id pub-id-type="doi">10.1083/jcb.201211138</pub-id>
</citation>
</ref>
<ref id="B25">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tkach</surname> <given-names>M</given-names>
</name>
<name>
<surname>Th&#xe9;ry</surname> <given-names>C</given-names>
</name>
</person-group>. <article-title>Communication by extracellular vesicles: where we are and where we need to go</article-title>. (<year>2016</year>) <source>Cellpress</source> <volume>164</volume>:<fpage>Cell</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cell.2016.01.043</pub-id>
</citation>
</ref>
<ref id="B26">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Silverman</surname> <given-names>JM</given-names>
</name>
<name>
<surname>Clos</surname> <given-names>J</given-names>
</name>
<name>
<surname>De&#x2019;Oliveira</surname> <given-names>CC</given-names>
</name>
<name>
<surname>Shirvani</surname> <given-names>O</given-names>
</name>
<name>
<surname>Fang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>An exosome-based secretion pathway is responsible for protein export from Leishmania and communication with macrophages</article-title>. <source>J Cell Sci</source> (<year>2010</year>) <volume>123</volume>(<issue>6</issue>). doi: <pub-id pub-id-type="doi">10.1242/jcs.056465</pub-id>
</citation>
</ref>
<ref id="B27">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Silverman</surname> <given-names>JM</given-names>
</name>
<name>
<surname>Clos</surname> <given-names>J</given-names>
</name>
<name>
<surname>Horakova</surname> <given-names>E</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>AY</given-names>
</name>
<name>
<surname>Wiesgigl</surname> <given-names>M</given-names>
</name>
<name>
<surname>Kelly</surname> <given-names>I</given-names>
</name>
<etal/>
</person-group>. <article-title>Leishmania exosomes modulate innate and adaptive immune responses through effects on monocytes and dendritic cells</article-title>. <source>J Immunol</source> (<year>2010</year>) <volume>185</volume>(<issue>9</issue>). doi: <pub-id pub-id-type="doi">10.4049/jimmunol.1000541</pub-id>
</citation>
</ref>
<ref id="B28">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hassani</surname> <given-names>K</given-names>
</name>
<name>
<surname>Shio</surname> <given-names>MT</given-names>
</name>
<name>
<surname>Martel</surname> <given-names>C</given-names>
</name>
<name>
<surname>Faubert</surname> <given-names>D</given-names>
</name>
<name>
<surname>Olivier</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Absence of metalloprotease GP63 alters the protein content of leishmania exosomes</article-title>. <source>PloS One</source> (<year>2014</year>) <volume>9</volume>(<issue>4</issue>). doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0095007</pub-id>
</citation>
</ref>
<ref id="B29">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Atayde</surname> <given-names>VD</given-names>
</name>
<name>
<surname>Aslan</surname> <given-names>H</given-names>
</name>
<name>
<surname>Townsend</surname> <given-names>S</given-names>
</name>
<name>
<surname>Hassani</surname> <given-names>K</given-names>
</name>
<name>
<surname>Kamhawi</surname> <given-names>S</given-names>
</name>
<name>
<surname>Olivier</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Exosome secretion by the parasitic protozoan leishmania within the sand fly midgut</article-title>. <source>Cell Rep</source> (<year>2015</year>) <volume>13</volume>(<issue>5</issue>). doi: <pub-id pub-id-type="doi">10.1016/j.celrep.2015.09.058</pub-id>
</citation>
</ref>
<ref id="B30">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alcolea</surname> <given-names>PJ</given-names>
</name>
<name>
<surname>Alonso</surname> <given-names>A</given-names>
</name>
<name>
<surname>Degay&#xf3;n</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Moreno-Paz</surname> <given-names>M</given-names>
</name>
<name>
<surname>Jim&#xe9;nez</surname> <given-names>M</given-names>
</name>
<name>
<surname>Molina</surname> <given-names>R</given-names>
</name>
<etal/>
</person-group>. <article-title>
<italic>In vitro</italic> infectivity and differential gene expression of Leishmania infantum metacyclic promastigotes: Negative selection with peanut agglutinin in culture versus isolation from the stomodeal valve of Phlebotomus perniciosus</article-title>. <source>BMC Genomics</source> (<year>2016</year>) <volume>17</volume>(<issue>1</issue>). doi: <pub-id pub-id-type="doi">10.1186/s12864-016-2672-8</pub-id>
</citation>
</ref>
<ref id="B31">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hassani</surname> <given-names>K</given-names>
</name>
<name>
<surname>Antoniak</surname> <given-names>E</given-names>
</name>
<name>
<surname>Jardim</surname> <given-names>A</given-names>
</name>
<name>
<surname>Olivier</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Temperature-induced protein secretion by leishmania mexicana modulates macrophage signalling and function</article-title>. <source>PloS One</source> (<year>2011</year>) <volume>6</volume>(<issue>5</issue>). doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0018724</pub-id>
</citation>
</ref>
<ref id="B32">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Silverman</surname> <given-names>JM</given-names>
</name>
<name>
<surname>Reiner</surname> <given-names>NE</given-names>
</name>
</person-group>. <article-title>Leishmania exosomes deliver preemptive strikes to create an environment permissive for early infection</article-title>. <source>Front Cell Infection Microbiol</source> (<year>2011</year>) <volume>1</volume>. doi: <pub-id pub-id-type="doi">10.3389/fcimb.2011.00026</pub-id>
</citation>
</ref>
<ref id="B33">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dragovic</surname> <given-names>RA</given-names>
</name>
<name>
<surname>Gardiner</surname> <given-names>C</given-names>
</name>
<name>
<surname>Brooks</surname> <given-names>AS</given-names>
</name>
<name>
<surname>Tannetta</surname> <given-names>DS</given-names>
</name>
<name>
<surname>Ferguson</surname> <given-names>DJP</given-names>
</name>
<name>
<surname>Hole</surname> <given-names>P</given-names>
</name>
<etal/>
</person-group>. <article-title>Sizing and phenotyping of cellular vesicles using Nanoparticle Tracking Analysis</article-title>. <source>Nanomedicine</source> (<year>2011</year>) <volume>7</volume>(<issue>6</issue>):<page-range>780&#x2013;8</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.nano.2011.04.003</pub-id>
</citation>
</ref>
<ref id="B34">
<label>34</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>L&#xf6;tvall</surname> <given-names>J</given-names>
</name>
<name>
<surname>Hill</surname> <given-names>AF</given-names>
</name>
<name>
<surname>Hochberg</surname> <given-names>F</given-names>
</name>
<name>
<surname>Buz&#xe1;s</surname> <given-names>EI</given-names>
</name>
<name>
<surname>Di Vizio</surname> <given-names>D</given-names>
</name>
<name>
<surname>Gardiner</surname> <given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the International Society for Extracellular Vesicles</article-title>. <source>J Extracell Vesicles</source> (<year>2014</year>) <volume>3</volume>(<issue>1</issue>):<fpage>26913</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3402/jev.v3.26913</pub-id>
</citation>
</ref>
<ref id="B35">
<label>35</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cruz</surname> <given-names>FF</given-names>
</name>
<name>
<surname>Borg</surname> <given-names>ZD</given-names>
</name>
<name>
<surname>Goodwin</surname> <given-names>M</given-names>
</name>
<name>
<surname>Sokocevic</surname> <given-names>D</given-names>
</name>
<name>
<surname>Wagner</surname> <given-names>DE</given-names>
</name>
<name>
<surname>Coffey</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Systemic administration of human bone marrow-derived mesenchymal stromal cell extracellular vesicles ameliorates <italic>aspergillus</italic> hyphal extract-induced allergic airway inflammation in immunocompetent mice</article-title>. <source>Stem Cells Transl Med</source> (<year>2015</year>) <volume>4</volume>(<issue>11</issue>):<page-range>1302&#x2013;16</page-range>. doi: <pub-id pub-id-type="doi">10.5966/sctm.2014-0280</pub-id>
</citation>
</ref>
<ref id="B36">
<label>36</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Giudice</surname> <given-names>A</given-names>
</name>
<name>
<surname>Vendrame</surname> <given-names>C</given-names>
</name>
<name>
<surname>Bezerra</surname> <given-names>C</given-names>
</name>
<name>
<surname>Carvalho</surname> <given-names>LP</given-names>
</name>
<name>
<surname>Delavechia</surname> <given-names>T</given-names>
</name>
<name>
<surname>Carvalho</surname> <given-names>EM</given-names>
</name>
<etal/>
</person-group>. <article-title>Macrophages participate in host protection and the disease pathology associated with Leishmania Braziliensis infection</article-title>. <source>BMC Infect Dis</source> (<year>2012</year>) <volume>12</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/1471-2334-12-75</pub-id>
</citation>
</ref>
<ref id="B37">
<label>37</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Almeida</surname> <given-names>L</given-names>
</name>
<name>
<surname>Silva</surname> <given-names>JA</given-names>
</name>
<name>
<surname>Andrade</surname> <given-names>VM</given-names>
</name>
<name>
<surname>MaChado</surname> <given-names>P</given-names>
</name>
<name>
<surname>Jamieson</surname> <given-names>SE</given-names>
</name>
<name>
<surname>Carvalho</surname> <given-names>EM</given-names>
</name>
<etal/>
</person-group>. <article-title>Analysis of expression of FLI1 and MMP1 in American cutaneous leishmaniasis caused by Leishmania Braziliensis infection</article-title>. <source>Infection Genet Evol</source> (<year>2017</year>) <volume>49</volume>. doi: <pub-id pub-id-type="doi">10.1016/j.meegid.2017.01.018</pub-id>
</citation>
</ref>
<ref id="B38">
<label>38</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vandanmagsar</surname> <given-names>B</given-names>
</name>
<name>
<surname>Youm</surname> <given-names>YH</given-names>
</name>
<name>
<surname>Ravussin</surname> <given-names>A</given-names>
</name>
<name>
<surname>Galgani</surname> <given-names>JE</given-names>
</name>
<name>
<surname>Stadler</surname> <given-names>K</given-names>
</name>
<name>
<surname>Mynatt</surname> <given-names>RL</given-names>
</name>
<etal/>
</person-group>. <article-title>The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance</article-title>. <source>Nat Med</source> (<year>2011</year>) <volume>17</volume>(<issue>2</issue>). doi: <pub-id pub-id-type="doi">10.1038/nm.2279</pub-id>
</citation>
</ref>
<ref id="B39">
<label>39</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lima-Junior</surname> <given-names>DS</given-names>
</name>
<name>
<surname>Costa</surname> <given-names>DL</given-names>
</name>
<name>
<surname>Carregaro</surname> <given-names>V</given-names>
</name>
<name>
<surname>Cunha</surname> <given-names>LD</given-names>
</name>
<name>
<surname>Silva</surname> <given-names>ALN</given-names>
</name>
<name>
<surname>Mineo</surname> <given-names>TWP</given-names>
</name>
<etal/>
</person-group>. <article-title>Inflammasome-derived IL-1&#x3b2; production induces nitric oxide-mediated resistance to Leishmania</article-title>. <source>Nat Med</source> (<year>2013</year>) <volume>19</volume>(<issue>7</issue>). doi: <pub-id pub-id-type="doi">10.1038/nm.3221</pub-id>
</citation>
</ref>
<ref id="B40">
<label>40</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marim</surname> <given-names>FM</given-names>
</name>
<name>
<surname>Silveira</surname> <given-names>TN</given-names>
</name>
<name>
<surname>Lima</surname> <given-names>DS</given-names>
</name>
<name>
<surname>Zamboni</surname> <given-names>DS</given-names>
</name>
</person-group>. <article-title>A method for generation of bone marrow-derived macrophages from cryopreserved mouse bone marrow cells</article-title>. <source>PloS One</source> (<year>2010</year>) <volume>5</volume>(<issue>12</issue>). doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0015263</pub-id>
</citation>
</ref>
<ref id="B41">
<label>41</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Netea</surname> <given-names>MG</given-names>
</name>
<name>
<surname>Latz</surname> <given-names>E</given-names>
</name>
<name>
<surname>Mills</surname> <given-names>KHG</given-names>
</name>
<name>
<surname>O&#x2019;Neill</surname> <given-names>LAJ</given-names>
</name>
</person-group>. <article-title>Innate immune memory: A paradigm shift in understanding host defense</article-title>. <source>Nat Immunol</source> (<year>2015</year>) <volume>16</volume>:<page-range>675&#x2013;9</page-range>. doi: <pub-id pub-id-type="doi">10.1038/ni.3178</pub-id>
</citation>
</ref>
<ref id="B42">
<label>42</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rizzetto</surname> <given-names>L</given-names>
</name>
<name>
<surname>Ifrim</surname> <given-names>DC</given-names>
</name>
<name>
<surname>Moretti</surname> <given-names>S</given-names>
</name>
<name>
<surname>Tocci</surname> <given-names>N</given-names>
</name>
<name>
<surname>Cheng</surname> <given-names>SC</given-names>
</name>
<name>
<surname>Quintin</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Fungal chitin induces trained immunity in human monocytes during cross-talk of the host with Saccharomyces cerevisiae</article-title>. <source>J Biol Chem</source> (<year>2016</year>) <volume>291</volume>(<issue>15</issue>). doi: <pub-id pub-id-type="doi">10.1074/jbc.M115.699645</pub-id>
</citation>
</ref>
<ref id="B43">
<label>43</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Connolly</surname> <given-names>DJ</given-names>
</name>
<name>
<surname>Bowie</surname> <given-names>AG</given-names>
</name>
</person-group>. <article-title>The emerging role of human PYHIN proteins in innate immunity: Implications for health and disease</article-title>. <source>Biochem Pharmacol</source> (<year>2014</year>) <volume>92</volume>. doi: <pub-id pub-id-type="doi">10.1016/j.bcp.2014.08.031</pub-id>
</citation>
</ref>
<ref id="B44">
<label>44</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Man</surname> <given-names>SM</given-names>
</name>
<name>
<surname>Karki</surname> <given-names>R</given-names>
</name>
<name>
<surname>Kanneganti</surname> <given-names>TD</given-names>
</name>
</person-group>. <article-title>AIM2 inflammasome in infection, cancer, and autoimmunity: Role in DNA sensing, inflammation, and innate immunity</article-title>. <source>Eur J Immunol</source> (<year>2016</year>) <volume>46</volume>. doi: <pub-id pub-id-type="doi">10.1002/eji.201545839</pub-id>
</citation>
</ref>
<ref id="B45">
<label>45</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Novais</surname> <given-names>FO</given-names>
</name>
<name>
<surname>Carvalho</surname> <given-names>LP</given-names>
</name>
<name>
<surname>Passos</surname> <given-names>S</given-names>
</name>
<name>
<surname>Roos</surname> <given-names>DS</given-names>
</name>
<name>
<surname>Carvalho</surname> <given-names>EM</given-names>
</name>
<name>
<surname>Scott</surname> <given-names>P</given-names>
</name>
<etal/>
</person-group>. <article-title>Genomic profiling of human leishmania Braziliensis lesions identifies transcriptional modules associated with cutaneous immunopathology</article-title>. <source>J Invest Dermatol</source> (<year>2015</year>) <volume>135</volume>(<issue>1</issue>). doi: <pub-id pub-id-type="doi">10.1038/jid.2014.305</pub-id>
</citation>
</ref>
<ref id="B46">
<label>46</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carvalho</surname> <given-names>AM</given-names>
</name>
<name>
<surname>Viana</surname> <given-names>SM</given-names>
</name>
<name>
<surname>Andrade</surname> <given-names>BB</given-names>
</name>
<name>
<surname>Oliveira</surname> <given-names>F</given-names>
</name>
<name>
<surname>Valenzuela</surname> <given-names>JG</given-names>
</name>
<name>
<surname>Carvalho</surname> <given-names>EM</given-names>
</name>
<etal/>
</person-group>. <article-title>Immune response to linB13, a lutzomyia intermedia salivary protein correlates with disease severity in tegumentary leishmaniasis</article-title>. <source>Clin Infect Dis</source> (<year>2022</year>) <volume>75</volume>(<issue>10</issue>). doi: <pub-id pub-id-type="doi">10.1093/cid/ciac258</pub-id>
</citation>
</ref>
<ref id="B47">
<label>47</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carvalho</surname> <given-names>AM</given-names>
</name>
<name>
<surname>Fukutani</surname> <given-names>KF</given-names>
</name>
<name>
<surname>Sharma</surname> <given-names>R</given-names>
</name>
<name>
<surname>Curvelo</surname> <given-names>RP</given-names>
</name>
<name>
<surname>MIranda</surname> <given-names>JC</given-names>
</name>
<name>
<surname>Barral</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Seroconversion to Lutzomyia intermedia LinB-13 as a biomarker for developing cutaneous leishmaniasis</article-title>. <source>Sci Rep</source> (<year>2017</year>) <volume>7</volume>(<issue>1</issue>). doi: <pub-id pub-id-type="doi">10.1038/s41598-017-03345-0</pub-id>
</citation>
</ref>
<ref id="B48">
<label>48</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carvalho</surname> <given-names>LP</given-names>
</name>
<name>
<surname>Passos</surname> <given-names>S</given-names>
</name>
<name>
<surname>Schriefer</surname> <given-names>A</given-names>
</name>
<name>
<surname>Carvalho</surname> <given-names>EM</given-names>
</name>
</person-group>. <article-title>Protective and pathologic immune responses in human tegumentary leishmaniasis</article-title>. <source>Front Immunol</source> (<year>2012</year>) <volume>3</volume>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2012.00301</pub-id>
</citation>
</ref>
<ref id="B49">
<label>49</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carrera</surname> <given-names>L</given-names>
</name>
<name>
<surname>Gazzinelli</surname> <given-names>RT</given-names>
</name>
<name>
<surname>Badolato</surname> <given-names>R</given-names>
</name>
<name>
<surname>Hieny</surname> <given-names>S</given-names>
</name>
<name>
<surname>M&#xfc;ller</surname> <given-names>W</given-names>
</name>
<name>
<surname>K&#xfc;hn</surname> <given-names>R</given-names>
</name>
<etal/>
</person-group>. <article-title>Leishmania promastigotes selectively inhibit interleukin 12 induction in bone marrow-derived macrophages from susceptible and resistant mice</article-title>. <source>J Exp Med</source> (<year>1996</year>) <volume>183</volume>(<issue>2</issue>). doi: <pub-id pub-id-type="doi">10.1084/jem.183.2.515</pub-id>
</citation>
</ref>
<ref id="B50">
<label>50</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kane</surname> <given-names>MM</given-names>
</name>
<name>
<surname>Mosser</surname> <given-names>DM</given-names>
</name>
</person-group>. <article-title>Leishmania parasites and their ploys to disrupt macrophage activation</article-title>. <source>Curr Opin Hematol</source> (<year>2000</year>) <volume>7</volume>. doi: <pub-id pub-id-type="doi">10.1097/00062752-200001000-00006</pub-id>
</citation>
</ref>
<ref id="B51">
<label>51</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Forget</surname> <given-names>G</given-names>
</name>
<name>
<surname>Gregory</surname> <given-names>DJ</given-names>
</name>
<name>
<surname>Whitcombe</surname> <given-names>LA</given-names>
</name>
<name>
<surname>Olivier</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Role of host protein tyrosine phosphatase SHP-1 in Leishmania donovani-induced inhibition of nitric oxide production</article-title>. <source>Infect Immun</source> (<year>2006</year>) <volume>74</volume>(<issue>11</issue>). doi: <pub-id pub-id-type="doi">10.1128/IAI.00853-05</pub-id>
</citation>
</ref>
<ref id="B52">
<label>52</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shweash</surname> <given-names>M</given-names>
</name>
<name>
<surname>Adrienne McGachy</surname> <given-names>H</given-names>
</name>
<name>
<surname>Schroeder</surname> <given-names>J</given-names>
</name>
<name>
<surname>Neamatallah</surname> <given-names>T</given-names>
</name>
<name>
<surname>Bryant</surname> <given-names>CE</given-names>
</name>
<name>
<surname>Millington</surname> <given-names>O</given-names>
</name>
<etal/>
</person-group>. <article-title>Leishmania mexicana promastigotes inhibit macrophage IL-12 production via TLR-4 dependent COX-2, iNOS and arginase-1 expression</article-title>. <source>Mol Immunol</source> (<year>2011</year>) <volume>48</volume>(<issue>15&#x2013;16</issue>). doi: <pub-id pub-id-type="doi">10.1016/j.molimm.2011.05.013</pub-id>
</citation>
</ref>
<ref id="B53">
<label>53</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gupta</surname> <given-names>P</given-names>
</name>
<name>
<surname>Srivastav</surname> <given-names>S</given-names>
</name>
<name>
<surname>Saha</surname> <given-names>S</given-names>
</name>
<name>
<surname>Das</surname> <given-names>PK</given-names>
</name>
<name>
<surname>Ukil</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Leishmania donovani inhibits macrophage apoptosis and pro-inflammatory response through AKT-mediated regulation of &#x3b2;-catenin and FOXO-1</article-title>. <source>Cell Death Differ</source> (<year>2016</year>) <volume>23</volume>(<issue>11</issue>). doi: <pub-id pub-id-type="doi">10.1038/cdd.2016.101</pub-id>
</citation>
</ref>
<ref id="B54">
<label>54</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weinheber</surname> <given-names>N</given-names>
</name>
<name>
<surname>Wolfram</surname> <given-names>M</given-names>
</name>
<name>
<surname>Harbecke</surname> <given-names>D</given-names>
</name>
<name>
<surname>Aebischer</surname> <given-names>T</given-names>
</name>
</person-group>. <article-title>Phagocytosis of Leishmania mexicana amastigotes by macrophages leads to a sustained suppression of IL-12 production</article-title>. <source>Eur J Immunol</source> (<year>1998</year>) <volume>28</volume>(<issue>8</issue>). doi: <pub-id pub-id-type="doi">10.1002/(SICI)1521-4141(199808)28:08&lt;2467::AID-IMMU2467&gt;3.0.CO;2-1</pub-id>
</citation>
</ref>
<ref id="B55">
<label>55</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Parmar</surname> <given-names>N</given-names>
</name>
<name>
<surname>Chandrakar</surname> <given-names>P</given-names>
</name>
<name>
<surname>Vishwakarma</surname> <given-names>P</given-names>
</name>
<name>
<surname>Singh</surname> <given-names>K</given-names>
</name>
<name>
<surname>Mitra</surname> <given-names>K</given-names>
</name>
<name>
<surname>Kar</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Leishmania donovani exploits tollip, a multitasking protein, to impair TLR/IL-1R signaling for its survival in the host</article-title>. <source>J Immunol</source> (<year>2018</year>) <volume>201</volume>(<issue>3</issue>). doi: <pub-id pub-id-type="doi">10.4049/jimmunol.1800062</pub-id>
</citation>
</ref>
<ref id="B56">
<label>56</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cameron</surname> <given-names>P</given-names>
</name>
<name>
<surname>McGachy</surname> <given-names>A</given-names>
</name>
<name>
<surname>Anderson</surname> <given-names>M</given-names>
</name>
<name>
<surname>Paul</surname> <given-names>A</given-names>
</name>
<name>
<surname>Coombs</surname> <given-names>GH</given-names>
</name>
<name>
<surname>Mottram</surname> <given-names>JC</given-names>
</name>
<etal/>
</person-group>. <article-title>Inhibition of lipopolysaccharide-induced macrophage IL-12 production by leishmania mexicana amastigotes: the role of cysteine peptidases and the NF-&#x3ba;B signaling pathway</article-title>. <source>J Immunol</source> (<year>2004</year>) <volume>173</volume>(<issue>5</issue>). doi: <pub-id pub-id-type="doi">10.4049/jimmunol.173.5.3297</pub-id>
</citation>
</ref>
<ref id="B57">
<label>57</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gomez</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Contreras</surname> <given-names>I</given-names>
</name>
<name>
<surname>Hall&#xe9;</surname> <given-names>M</given-names>
</name>
<name>
<surname>Tremblay</surname> <given-names>ML</given-names>
</name>
<name>
<surname>McMaster</surname> <given-names>RW</given-names>
</name>
<name>
<surname>Olivier</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Leishmania GP63 alters host signaling through cleavage-activated protein tyrosine phosphatases</article-title>. <source>Sci Signal</source> (<year>2009</year>) <volume>2</volume>(<issue>90</issue>). doi: <pub-id pub-id-type="doi">10.1126/scisignal.2000213</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>